Revenue | ₹15.10Cr |
Net Profits | ₹-79.51Cr |
Net Profit Margins | -526.56% |
Sun Pharma Advanced Research Company Ltd’s revenue fell -25.43% since last year same period to ₹15.10Cr in the Q3 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 17.05% jump in its revenue since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit jumped 20.21% since last year same period to ₹-79.51Cr in the Q3 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 25.92% jump in its net profits since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit margin fell -7% since last year same period to -526.56% in the Q3 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 36.71% jump in its net profit margins since last 3-months.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q3 results 2024 was ₹15.10Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q3 results 2024 was ₹-79.51Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q3 results 2024 was -526.56%.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q3 results 2023 was ₹20.25Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q3 results 2023 was ₹-99.65Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q3 results 2023 was -492.10%.